SOX2 and neoplasm: The aim of this study to explore SOX2 and AGR2 biomarkers expression in tumor tissue of ER-positive breast cancer patients in combination with estimation of serum AGR2 level of these patients in order to validate these biomarkers in the early prediction of tamoxifen resistance.